Haleon Announces the Launch of Eroxon®, The First and Only FDA Cleared OTC Gel for Erectile Dysfunction, Available for U.S. Preorder Without a Prescription [Yahoo! Finance]
Haleon plc American Depositary Shares (Each representing two Ordinary Shares) (HLN)
Company Research
Source: Yahoo! Finance
Eroxon ® is available now for Amazon pre-order; available on shelves and online at most major retailers in October 2024 WARREN, N.J. Sept. 3, 2024 /PRNewswire/ -- Eroxon ® , the first-and-only FDA cleared gel available without a prescription for the treatment of erectile dysfunction (ED), is now available for pre-order in the United States through Amazon and will be available at most major retailers in October 2024 Eroxon ® is clinically proven to help men get an erection within 10 minutes to foster physical intimacy (individual results may vary). The treatment stimulates nerve endings in the penis to help men with ED get and maintain an erection during sex. Given existing prescription solutions may take up to an hour to work (based on labels), Eroxon ® addresses a significant unmet need for men experiencing ED. Clinical study results show that Eroxon ® is safe and effective in men with ED. While ED can be caused by underlying physical conditions, psychological challenges such
Show less
Read more
Impact Snapshot
Event Time:
HLN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HLN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HLN alerts
High impacting Haleon plc American Depositary Shares (Each representing two Ordinary Shares) news events
Weekly update
A roundup of the hottest topics
HLN
News
- Sensodyne maker Haleon to raise stake in China JV [Yahoo! Finance]Yahoo! Finance
- Analysts agree that Kenvue's Neutrogena needs a face-lift [Seeking Alpha]Seeking Alpha
- Haleon plc (NYSE: HLN) had its price target raised by analysts at Morgan Stanley from $9.90 to $10.95. They now have an "overweight" rating on the stock.MarketBeat
- Haleon (LSE:HLN) Eyes Bolt-On M&A and New Product Launches to Drive Growth Despite High Valuation Concerns [Yahoo! Finance]Yahoo! Finance
- Estimating The Fair Value Of Haleon plc (LON:HLN) [Yahoo! Finance]Yahoo! Finance
HLN
Sec Filings
- 9/27/24 - Form 6-K
- 9/27/24 - Form 6-K
- 9/26/24 - Form 6-K
- HLN's page on the SEC website